Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss

Obesity (Silver Spring). 2014 Feb;22(2):356-62. doi: 10.1002/oby.20524. Epub 2013 Sep 4.

Abstract

Objective: To determine whether the expression of key asthma related genes, IL-4, LIGHT, LTBR, MMP-9, CCR-2, and ADAM-33 in mononuclear cells and the plasma concentration of nitric oxide metabolites (NOM) and MMP-9 are increased in the obese, obese type 2 diabetics (T2DM) and in morbidly obese patients prior to and after gastric bypass surgery (RYGB).

Design and methods: The expression of these genes in MNC and plasma concentrations of these indices was measured in healthy lean and in obese with and without T2DM and following RYGB in obese T2DM.

Results: The expression of IL-4, MMP-9, LIGHT and CCR-2 and plasma NOM concentrations was significantly higher in the obese subjects and in obese T2DM patients than in normal subjects. The expression of IL-4, LIGHT, MMP-9, and CCR-2 expression was related to BMI and HOMA-IR. The expression of IL-4, LIGHT, LTBR, ADAM-33, MMP-9, and CCR-2 fell after RYGB surgery as did plasma concentrations of MMP-9 and NOM.

Conclusions: Obesity with and without T2DM is associated with an increase in the expression of IL-4, LIGHT, MMP-9 and CCR-2; plasma NOM and MMP-9 concentrations are also increased. Following RYGB surgery and weight loss, the expression of these factors in MNC and plasma concentrations falls significantly.

Trial registration: ClinicalTrials.gov NCT00960765.

Publication types

  • Controlled Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Asthma / complications
  • Asthma / prevention & control*
  • Body Mass Index
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / immunology*
  • Diabetes Mellitus, Type 2 / metabolism
  • Female
  • Follow-Up Studies
  • Gastric Bypass
  • Gene Expression Regulation
  • Humans
  • Inflammation Mediators / blood
  • Inflammation Mediators / metabolism*
  • Insulin Resistance
  • Interleukin-4 / genetics
  • Interleukin-4 / metabolism
  • Leukocytes, Mononuclear / immunology*
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Matrix Metalloproteinase 9 / blood
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • Middle Aged
  • Nitric Oxide / blood
  • Obesity / blood
  • Obesity / complications
  • Obesity / immunology*
  • Obesity / metabolism
  • Obesity, Morbid / complications
  • Obesity, Morbid / immunology
  • Obesity, Morbid / metabolism
  • Obesity, Morbid / surgery*
  • Receptors, CCR2 / genetics
  • Receptors, CCR2 / metabolism
  • Tumor Necrosis Factor Ligand Superfamily Member 14 / genetics
  • Tumor Necrosis Factor Ligand Superfamily Member 14 / metabolism
  • Weight Loss*

Substances

  • CCR2 protein, human
  • IL4 protein, human
  • Inflammation Mediators
  • Receptors, CCR2
  • TNFSF14 protein, human
  • Tumor Necrosis Factor Ligand Superfamily Member 14
  • Interleukin-4
  • Nitric Oxide
  • MMP9 protein, human
  • Matrix Metalloproteinase 9

Associated data

  • ClinicalTrials.gov/NCT00960765